GERN Geron Corporation Stock Quote

GERN [NASD]

Index	-	P/E	-	EPS (ttm)	-0.29	Insider Own	0.17%	Shs Outstand	323.64M	Perf Week	-6.15%
Market Cap	391.80M	Forward P/E	-	EPS next Y	-0.40	Insider Trans	0.00%	Shs Float	318.02M	Perf Month	-13.48%
Income	-87.10M	PEG	-	EPS next Q	-0.09	Inst Own	46.30%	Short Float	7.53%	Perf Quarter	-10.95%
Sales	0.30M	P/S	1306.01	EPS this Y	22.70%	Inst Trans	-0.04%	Short Ratio	2.85	Perf Half Y	-41.90%
Book/sh	0.62	P/B	1.97	EPS next Y	-2.90%	ROA	-32.00%	Target Price	-	Perf Year	-29.48%
Cash/sh	0.66	P/C	1.86	EPS next 5Y	5.00%	ROE	-38.90%	52W Range	1.20 - 2.36	Perf YTD	-23.27%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-32.70%	52W High	-47.77%	Beta	1.09
Dividend %	-	Quick Ratio	7.50	Sales past 5Y	-63.00%	Gross Margin	-	52W Low	2.50%	ATR	0.07
Employees	53	Current Ratio	7.50	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	40.70	Volatility	4.87% 5.24%
Optionable	Yes	Debt/Eq	0.12	EPS Q/Q	-5.30%	Profit Margin	-	Rel Volume	0.19	Prev Close	1.22
Shortable	Yes	LT Debt/Eq	0.12	Earnings	May 10 AMC	Payout	-	Avg Volume	8.39M	Price	1.23
Recom	1.80	SMA20	-4.02%	SMA50	-11.43%	SMA200	-24.28%	Volume	231,937	Change	0.82%

Feb-18-21

Resumed

B. Riley Securities

Buy

Aug-03-20

Initiated

Stifel

Buy

Nov-19-19

Resumed

B. Riley FBR

Buy

Sep-03-19

Initiated

H.C. Wainwright

Buy

Aug-15-19

Initiated

Cantor Fitzgerald

Overweight

Apr-09-19

Upgrade

Needham

Hold → Buy

Jan-31-19

Upgrade

B. Riley FBR

Neutral → Buy

$1.50 → $3.25

Oct-02-18

Downgrade

B. Riley FBR

Buy → Neutral

$5.75 → $1.50

Jul-05-18

Initiated

B. Riley FBR, Inc.

Buy

$5.75

Sep-13-16

Reiterated

FBR Capital

Outperform

$6 → $5

Sep-13-16

Reiterated

FBR & Co.

Outperform

$6 → $5

Dec-07-15

Reiterated

Piper Jaffray

Overweight

$5 → $10

Apr-21-15

Initiated

Oppenheimer

Outperform

$5.50

Jun-12-14

Upgrade

MLV & Co

Hold → Buy

$2 → $4.25

Mar-12-14

Downgrade

MLV & Co

Buy → Hold

$9 → $2

Dec-10-13

Upgrade

Needham

Hold → Buy

$10

Dec-10-13

Reiterated

MLV & Co

Buy

$8 → $9

Nov-08-13

Reiterated

MLV & Co

Buy

$6.50 → $8

Oct-16-13

Initiated

MLV & Co

Buy

$6.50

Aug-30-12

Initiated

Stifel Nicolaus

Buy

Aug-02-21 06:09AM	Do Institutions Own Geron Corporation (NASDAQ:GERN) Shares? Simply Wall St.
Jul-29-21 03:05PM	Earnings Preview: Geron (GERN) Q2 Earnings Expected to Decline Zacks -5.38%
Jul-22-21 04:45PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jun-21-21 12:15PM	Geron (GERN) Soars on Imetelstat Data for Myelofibrosis Zacks -7.10%
08:36AM	Do Options Traders Know Something About Geron (GERN) Stock We Don't? Zacks
Jun-18-21 11:40AM	Why Geron Stock Is Soaring Today Motley Fool +29.79%
10:04AM	Geron Skyrockets on Bone Marrow Cancer Treatment Trial TheStreet.com
06:31AM	Geron Stock Trading Is Higher On Reinforcing Imetelstat's Approach For Myelofibrosis Treatment, With Data Publication In Journal Benzinga
Jun-17-21 04:30PM	Geron Announces Publication of IMbark Phase 2 Data in Journal of Clinical Oncology Business Wire
Jun-14-21 04:30PM	Geron Reports Two Presentations at Virtual European Hematology Association Annual Congress Business Wire
May-12-21 10:56AM	Geron Announces Two Presentations at Upcoming European Hematology Association Annual Congress Business Wire
May-11-21 02:01AM	Geron (GERN) Q1 2021 Earnings Call Transcript Motley Fool +11.20%
May-10-21 05:55PM	Geron (GERN) Reports Q1 Loss, Tops Revenue Estimates Zacks -6.02%
04:05PM	Geron Corporation Reports First Quarter 2021 Financial Results and Recent Highlights Business Wire
May-04-21 10:37AM	Here's Why It's Unlikely That Geron Corporation's (NASDAQ:GERN) CEO Will See A Pay Rise This Year Simply Wall St.
May-03-21 04:30PM	Geron to Announce First Quarter 2021 Financial Results on May 10, 2021 Business Wire
Apr-27-21 04:36AM	SHAREHOLDER ALERT: Barr Law Group Investigating GERN, MIE, CG, and EVF; Shareholders are Encouraged to Contact the Firm GlobeNewswire
Apr-22-21 04:30PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Apr-20-21 04:01PM	GERON CORPORATION INVESTOR ALERT: Geron Investors Who Have Held Their Stock Continuously Since At Least March 2018 Encouraged To Contact Kehoe Law Firm, P.C. GlobeNewswire
Apr-19-21 09:30AM	SHAREHOLDER ALERT: Geron Corporation (GERN) Officers and Directors Under Investigation for False Statements and Insider Trading PR Newswire
Apr-18-21 08:00AM	Lifshitz Law Firm, P.C. Announces Investigations of Geron Corp. (NasdaqGS: GERN), Jeld-Wen Holding, Inc. (NYSE: JELD), and Oracle Corporation (NYSE: ORCL) GlobeNewswire
Apr-14-21 09:40AM	Geron (GERN) Begins Phase III Myelofibrosis Study on Imetelstat Zacks +5.59%
Apr-13-21 07:30AM	Geron Announces First Patient Dosed in IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis Business Wire
Mar-18-21 04:45PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Mar-12-21 12:06PM	Why Geron Corporation Stock Is Falling Today Motley Fool -8.99%
08:00AM	Gene editing will boost intelligence within a few decades Yahoo Finance Video
03:00AM	Geron (GERN) Q4 2020 Earnings Call Transcript Motley Fool
Mar-11-21 04:10PM	Geron Corporation Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights Business Wire
07:00AM	Influencers with Andy Serwer: Walter Isaacson Yahoo Finance Video
Mar-10-21 10:08AM	Geron's Earnings Outlook Benzinga
Mar-04-21 12:30PM	Geron (GERN) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
Mar-01-21 04:45PM	Geron to Announce Fourth Quarter and Full Year 2020 Financial Results on March 11, 2021 Business Wire
Feb-18-21 04:45PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Feb-07-21 03:54AM	Is Geron (NASDAQ:GERN) Weighed On By Its Debt Load? Simply Wall St.
Jan-21-21 04:45PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jan-14-21 04:45PM	Geron to Present at the B. Riley Securities Virtual Oncology Investor Conference Business Wire
Dec-17-20 01:25PM	Is GERN A Good Stock To Buy Now? Insider Monkey
Dec-11-20 08:30AM	Geron Announces Opening of IMpactMF Phase 3 Clinical Trial in Refractory Myelofibrosis Business Wire
Dec-10-20 08:30AM	Geron Announces Fifty Percent Enrollment Milestone in IMerge Phase 3 Clinical Trial in Lower Risk MDS Business Wire
Dec-07-20 06:45PM	Geron Reports Ten Imetelstat Presentations at American Society of Hematology Annual Meeting Business Wire
Nov-19-20 04:30PM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Nov-10-20 04:30PM	Geron to Present at the Stifel Virtual Healthcare Conference Business Wire
Nov-08-20 07:51AM	Time To Worry? Analysts Just Downgraded Their Geron Corporation (NASDAQ:GERN) Outlook Simply Wall St.
Nov-06-20 10:31AM	Geron (GERN) Q3 2020 Earnings Call Transcript Motley Fool
Nov-05-20 07:20PM	Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:25PM	Recap: Geron Q3 Earnings Benzinga
04:05PM	Geron Corporation Reports Third Quarter 2020 Financial Results and Current Events GlobeNewswire
Nov-04-20 04:27PM	Geron Announces Ten Imetelstat Presentations at Upcoming American Society of Hematology Annual Meeting Business Wire
Nov-02-20 11:58AM	Qorvo, Nikola, BMY, MyoKardia and Geron as Zacks Bull and Bear of the Day Zacks
Oct-29-20 04:30PM	Geron to Announce Third Quarter Financial Results on November 5, 2020 Business Wire
Oct-28-20 04:35PM	Geron Announces Publication of IMerge Phase 2 Data in Journal of Clinical Oncology Business Wire
12:32PM	Geron (GERN) Expected to Beat Earnings Estimates: Should You Buy? Zacks
Oct-23-20 09:03AM	Is Geron Corporation (NASDAQ:GERN) Popular Amongst Institutions? Simply Wall St.
Oct-01-20 04:30PM	Geron Secures Loan Facility for Up to $75 Million Business Wire
Sep-21-20 08:53AM	Geron (GERN) Looks Good: Stock Adds 6.5% in Session Zacks
Sep-17-20 04:30PM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Sep-09-20 09:00AM	Geron to Present at the H.C. Wainwright Global Investment Conference Business Wire
Aug-24-20 10:52AM	How Should Investors Feel About Geron's (NASDAQ:GERN) CEO Remuneration? Simply Wall St.
Aug-20-20 04:30PM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Aug-06-20 04:05PM	Geron Corporation Reports Second Quarter 2020 Financial Results and Current Events Business Wire
Aug-04-20 04:45PM	Geron to Present at the BTIG Virtual Biotechnology Conference Business Wire
Jul-30-20 04:30PM	Geron to Announce Second Quarter Financial Results on August 6, 2020 Business Wire
12:33PM	Will Geron (GERN) Report Negative Q2 Earnings? What You Should Know Zacks
Jul-27-20 08:28AM	Geron Sees Hammer Chart Pattern: Time to Buy? Zacks
08:18AM	Geron Sees Hammer Chart Pattern: Time to Buy? Zacks
Jul-23-20 11:30AM	Is Geron (GERN) Stock Outpacing Its Medical Peers This Year? Zacks
Jul-16-20 08:30AM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Jul-01-20 08:30AM	Geron Receives Positive Opinion from the EMA Committee for Orphan Medicinal Products for Orphan Drug Designation in the European Union for Imetelstat to Treat Myelodysplastic Syndromes GlobeNewswire
Jun-30-20 08:01AM	Edited Transcript of GERN earnings conference call or presentation 28-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-25-20 10:36AM	Zealand Announces Dosing Initiation in Type 2 Diabetes Study Zacks
08:38AM	Geron's Shares March Higher, Can It Continue? Zacks
Jun-24-20 12:35PM	Brokers Are Upgrading Their Views On Geron Corporation (NASDAQ:GERN) With These New Forecasts Simply Wall St.
11:30AM	Is Geron (GERN) Stock Outpacing Its Medical Peers This Year? Zacks
Jun-22-20 11:28AM	Dynavax's Partner Doses First Patient in Coronavirus Study Zacks
Jun-19-20 08:50AM	Implied Volatility Surging for Geron Corporation (GERN) Stock Options Zacks
Jun-12-20 08:30AM	Geron Reports Four Imetelstat Data Presentations at Virtual Edition of the European Hematology Association (EHA) Annual Congress GlobeNewswire
Jun-11-20 09:04AM	Moving Average Crossover Alert: Geron Zacks -8.84%
Jun-10-20 09:30AM	Dynavax Closes Enrollment in Renal Disease Study on Heplisav-B Zacks +7.10%
Jun-09-20 09:44AM	Top Ranked Momentum Stocks to Buy for June 9th Zacks
08:40AM	How Geron Corporation (GERN) Stock Stands Out in a Strong Industry Zacks
Jun-05-20 11:30AM	Is Geron (GERN) Outperforming Other Medical Stocks This Year? Zacks
07:29AM	Top Ranked Momentum Stocks to Buy for June 5th Zacks
Jun-02-20 09:08AM	Top Ranked Momentum Stocks to Buy for June 2nd Zacks
May-29-20 05:00PM	Geron Corporation (Delaware) (GERN) Q1 2020 Earnings Call Transcript Motley Fool
May-28-20 06:25PM	Geron (GERN) Reports Q1 Loss, Lags Revenue Estimates Zacks
04:05PM	Geron Corporation Reports First Quarter 2020 Financial Results GlobeNewswire
May-27-20 04:30PM	Geron Corporation Announces the Closing of its Public Offering of Common Stock and Warrants GlobeNewswire
May-22-20 11:11AM	P/E Ratio Insights for Geron Benzinga -6.12%
08:13AM	Geron's stock tumbles after large share offering prices at 34% discount MarketWatch
07:15AM	Geron Corporation Announces the Pricing of its Public Offering of Common Stock and Warrants GlobeNewswire
May-21-20 04:03PM	Geron Corporation Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire
04:01PM	Geron Announces Plans for Imetelstat Phase 3 Clinical Trial in Myelofibrosis and Other Updates GlobeNewswire
08:30AM	Geron Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Business Wire
May-15-20 01:24PM	Why Geron Stock Soared 23.4% Today Motley Fool +24.11%
May-14-20 02:22PM	3 Strong Buy Penny Stocks With Triple-Digit Upside TipRanks +6.82%
09:05AM	Geron Announces Four Imetelstat Presentations at the Virtual Edition of the European Hematology Association Annual Congress Business Wire
Apr-30-20 12:33PM	Earnings Preview: Geron (GERN) Q1 Earnings Expected to Decline Zacks
Apr-16-20 08:30AM	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Business Wire
Apr-09-20 06:08PM	Clinical trials in the age of COVID: Shelter-in-place, hospital restrictions cause drug study delays American City Business Journals
Apr-08-20 04:30PM	Geron to Present at Needham Virtual Healthcare Conference GlobeNewswire

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for hematologic myeloid malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hematologic myeloid malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
O'Farrell Elizabeth G.	Director	Aug 21	Buy	1.73	17,441	30,173	19,641	Aug 24 08:57 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience